Načítá se...
Tyrosol as a Neuroprotector: Strong Effects of a “Weak” Antioxidant
The use of neuroprotective agents for stroke is pathogenetically justified, but the translation of the results of preclinical studies of neuroprotectors into clinical practice has been a noticeable failure. One of the leading reasons for these failures is the one-target mechanism of their activity....
Uloženo v:
| Vydáno v: | Curr Neuropharmacol |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Bentham Science Publishers
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8206466/ https://ncbi.nlm.nih.gov/pubmed/32379590 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2174/1570159X18666200507082311 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|